VeriMomSollte ich thiabendazole in der Schwangerschaft meiden? | VeriMom
Thiabendazole has an EU harmonised classification that includes reproductive toxicity H360 (Category 1B / H360FD in CLP listings), which meets criteria for confirmed reproductive hazard. ECHA/CLP documents and the EU delegated regulation list H360 for thiabendazole, and multiple developmental/reproductive animal studies (rats, mice, rabbits) and JECFA/WHO monographs report fetal and developmental effects at toxic doses, supporting demonstrable mechanism(s) of developmental toxicity and systemic distribution. Sources: ECHA substance/factsheet and EU CLP entry; peer-reviewed developmental studies and JECFA monographs.
ECHA regulatory hazard statements
- •H400
- •H410
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- Ist thiabendazole in der Schwangerschaft sicher?
- Thiabendazole has an EU harmonised classification that includes reproductive toxicity H360 (Category 1B / H360FD in CLP listings), which meets criteria for confirmed reproductive hazard. ECHA/CLP documents and the EU delegated regulation list H360 for thiabendazole, and multiple developmental/reproductive animal studies (rats, mice, rabbits) and JECFA/WHO monographs report fetal and developmental effects at toxic doses, supporting demonstrable mechanism(s) of developmental toxicity and systemic distribution. Sources: ECHA substance/factsheet and EU CLP entry; peer-reviewed developmental studies and JECFA monographs.
- Ist thiabendazole während des Stillens sicher?
- Because of the harmonised H360 classification and animal/peer-reviewed data showing systemic absorption and distribution (including to fetal tissues) and developmental effects, thiabendazole is flagged for reproductive/developmental hazard that is relevant to lactation exposure. Human/animal ADME data show rapid absorption and systemic distribution; lactational transfer is plausible though milk-specific data are limited, so exposure to breastfed infants is considered low but measurable from systemic maternal exposure.
- Ist thiabendazole sicher für Babyhaut?
- Hazard and mechanism are not increased for infants absent infant‑specific hazard evidence, but the harmonised H360 classification and animal developmental findings indicate a high reproductive/developmental hazard. Dermal/topical exposure on baby skin is assigned a higher exposure score (+1) because infant skin has higher surface-area-to-weight and an immature barrier and thiabendazole has measurable systemic absorption in ADME studies, so topical use could give measurable systemic exposure in infants.
- Wie bewertet VeriMom thiabendazole?
- VeriMom bewertet thiabendazole mit 20/100 (hohes Risiko) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu thiabendazole?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu thiabendazole basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.